Works by Jeongha Mok


Results: 25
    1
    2
    3
    4

    Delamanid, linezolid, levofloxacin, and pyrazinamide for the treatment of patients with fluoroquinolone-sensitive multidrug-resistant tuberculosis (Treatment Shortening of MDR-TB Using Existing and New Drugs, MDR-END): study protocol for a phase II/III, multicenter, randomized, open-label clinical trial.

    Published in:
    2019
    By:
    • Lee, Myungsun;
    • Mok, Jeongha;
    • Kim, Deog Kyeom;
    • Shim, Tae Sun;
    • Koh, Won-Jung;
    • Jeon, Doosoo;
    • Lee, Taehoon;
    • Lee, Seung Heon;
    • Kim, Ju Sang;
    • Park, Jae Seuk;
    • Lee, Ji Yeon;
    • Kim, Song Yee;
    • Lee, Jae Ho;
    • Jo, Kyung-Wook;
    • Jhun, Byung Woo;
    • Kang, Young Ae;
    • Ahn, Joong Hyun;
    • Kim, Chang-Ki;
    • Shin, Soyoun;
    • Song, Taeksun
    Publication type:
    journal article
    5
    6
    7
    8
    9

    A prospective patient registry to monitor safety, effectiveness, and utilisation of bedaquiline in patients with multidrug-resistant tuberculosis in South Korea.

    Published in:
    BMC Infectious Diseases, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12879-022-07955-6
    By:
    • Shim, Tae Sun;
    • Pai, Helen;
    • Mok, JeongHa;
    • Lee, Seung Heon;
    • Kwon, Yong-Soo;
    • Choi, Jae Chol;
    • Park, JaeSeok;
    • Birmingham, Eileen;
    • Mao, Gary;
    • Alquier, Lori;
    • Davis, Kourtney;
    • Thoret-Bauchet, Florence;
    • Kim, Ji Hyun;
    • Kim, Hyeongyeong;
    • Bakare, Nyasha
    Publication type:
    Article
    10
    11
    12
    13
    14
    15
    16

    Improvement in Health-Related Quality of Life Following Antibiotic Treatment in Nontuberculous Mycobacterial Pulmonary Disease: Initial Analysis of the NTM-KOREA Cohort.

    Published in:
    Clinical Infectious Diseases, 2024, v. 78, n. 6, p. 1690, doi. 10.1093/cid/ciae131
    By:
    • Kwak, Nakwon;
    • Henkle, Emily;
    • Hwang, Hyeontaek;
    • Jeon, Doosoo;
    • Jhun, Byung Woo;
    • Jo, Kyung-Wook;
    • Kang, Young Ae;
    • Kim, Hyung-Jun;
    • Kim, Joong-Yub;
    • Kim, Young Ran;
    • Kwon, Yong-Soo;
    • Lee, Jae Ho;
    • Mok, Jeongha;
    • Park, Youngmok;
    • Shim, Tae Sun;
    • Sohn, Hojoon;
    • Whang, Jake;
    • Yim, Jae-Joon
    Publication type:
    Article
    17
    18
    19
    20

    Treatment shortening of drug-sensitive pulmonary tuberculosis using high-dose rifampicin for 3 months after culture conversion (Hi-DoRi-3): a study protocol for an open-label randomized clinical trial.

    Published in:
    Trials, 2022, v. 23, n. 1, p. 1, doi. 10.1186/s13063-022-06631-z
    By:
    • Kwak, Nakwon;
    • Jeon, Doosoo;
    • Park, Youngmok;
    • Kang, Young Ae;
    • Kim, Kyung Jong;
    • Kim, Young Ran;
    • Kwon, Byoung Soo;
    • Kwon, Yong-Soo;
    • Kim, Hyung-Jun;
    • Lee, Jae Ho;
    • Lee, Ji Yeon;
    • Lee, Jung-Kyu;
    • Mok, Jeongha;
    • Cheon, Minkyoung;
    • Park, Jiwon;
    • Hahn, Seokyung;
    • Yim, Jae-Joon
    Publication type:
    Article
    21
    22
    23
    24
    25